Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...
Coverage complications are not unusual in the U.S. healthcare system. But the challenge is magnified for these obesity ...
Patients using GLP-1 medications after joint replacement procedures to lose significant amounts of weight have a much lower risk of requiring revision surgeries, according to a Feb. 24 Medscape report ...
Discover a study where findings suggest that strategies targeting visceral fat reduction may aid in overactive bladder ...
Many employers and insurers are scaling back coverage and Medicare doesn’t cover the drugs for obesity. Meantime, some big ...
1d
Hosted on MSNWhat does your body shape say about your health?T he body positive movement has transformed how we view our bodies, encouraging self-acceptance and love. But beyond ...
The burden of obesity extends beyond its health effects. For example, a 2024 report estimated that obesity-related healthcare ...
C Bon Secours. Many people never see a doctor until something is wrong. But when it comes to taking care of your health, ...
Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...
Obesity surgery (also known as bariatric and metabolic surgery) is one of the most common reasons for people to do so called ‘medical tourism’ – where they travel to another country to have the ...
Skye Bioscience, Inc. (NASDAQ:SKYE) is making waves in the biopharmaceutical industry with its innovative approach to obesity treatment. The company's lead candidate, nimacimab, a CB1 negative ...
Higher BMI in early adulthood and midlife is linked to better memory performance, particularly in men and Black Americans, challenging traditional views on obesity and cognition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results